Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3261 – 3280
of
3979
Fosamprenavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/fosamprenavir
Appendix B: Geographic Opportunistic Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-4
Varicella-Zoster Virus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/varicella-zoster-virus
Infant Feeding for Individuals With HIV in the United States
https://clinicalinfo.hiv.gov/guidelines/perinatal/infant-feeding-individuals-hiv-united-states
Appendix D. Financial Disclosures
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/appendix-financial-disclosures
Appendix A: Short Intake Form for Persons with HIV Who Are Seeking Care
https://clinicalinfo.hiv.gov/guidelines/guidelines-caring-persons-hiv-disaster-areas/appendix-short-intake-form-persons-hiv-who
Nevirapine (Viramune, NVP)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-nevirapine-viramune
Table 3. Indications for Discontinuing and Restarting Opportunistic Infection Prophylaxis in HIV-Infected Adults and Adolescents
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/indications-discontinuing-and
Special Populations: Early (Acute and Recent) HIV Infection
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/early-acute-and-recent-hiv-infection
Antiretroviral Pregnancy Registry
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-pregnancy-registry
What to Start
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/what-start
Rilpivirine (Edurant, RPV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-rilpivirine-edurant
Lipodystrophies and Weight Gain
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/lipodystrophies-and-weight-gain
What Not to Use
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-not-use
Financial Disclosure
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/financial-disclosure
Tenofovir Alafenamide (Vemlidy, TAF)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-tenofovir-alafenamide-vemlidy
Syphilis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/syphilis
Doravirine
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/doravirine
Drug Abbreviations
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/drug-abbreviations
Appendix B: Hepatitis B Virus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-5
Pagination
First page
«
Previous page
‹
…
Page
160
Page
161
Page
162
Page
163
Current page
164
Page
165
Page
166
Page
167
Page
168
…
Next page
›
Last page
»